Mayne Pharma Group Ltd has released a press release.
2026 Half Year Media Release
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
In the deck
Story so far
Earlier from Mayne Pharma
- Half Yearly Report and Accounts
- Mayne Pharma Management Changes
- MYX to claim against Cosette, Avista & Mr David Burgstahler
- 2025 AGM presentation and business update
- Market Update
Later from Mayne Pharma
- 2026 Half Year Investor Presentation
- S&P DJI Announces March 2026 Quarterly Rebalance
- Mayne Pharma reports unaudited 3Q FY26 results
- Court awards MYX $13.27m for legal costs from Cosette
- Mayne Pharma receives $14.4m for legal costs from Cosette
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma